Malaria Vaccine Targets Immune Protection Across Species

New research published in Nature identifies CD8+ T-cell antigens that protect against malaria across different species and life stages of the parasite. Led by Professor Faith H. A. Osier at the University of Oxford, the study found these specific T-cells could offer universal protection, potentially paving the way for a more effective vaccine. This moves us closer to a vaccine that works for humans and could stop transmission, too.